DKSH expands Novartis partnership as seven analysts track DKSH stock
Published on 10/13/2026 at 07:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS- DKSH partnered with Novartis in Singapore on October 8, 2026, covering ophthalmology services.
- First-half 2026 net income rose 10.00 percent to CHF 101.10 million.
- The September 28, 2026 Grünenthal agreement covers up to eight Asia-Pacific markets.
- DKSH trades on SIX under ticker DKSH and is included in the SPI.
DKSH expanded its Novartis partnership in Singapore on October 8, 2026, while seven analysts were listed for DKSH stock in an October update. The agreement covers agency services for Novartis ophthalmology products, including distribution, marketing, credit and collection services, according to Cash.
Three expansion milestones
On July 19, 2026, DKSH reported first-half earnings per share of CHF 1.67, up from CHF 1.41 in the first half of 2025, while revenue reached CHF 5.48 billion and net income rose 10.00 percent to CHF 101.10 million, according to Simply Wall St.
On September 28, 2026, DKSH expanded its Grünenthal alliance to up to eight Asia-Pacific markets and four pain-management products, including Qutenza, Vimovo, Palexia and Zomig, according to finanzen.ch.
On October 8, 2026, the Novartis arrangement added a second healthcare expansion milestone within 11 days. The Singapore mandate gives DKSH responsibility across three commercial functions, linking the agreement to the company's existing healthcare distribution platform, as finanzen.ch reported.
What does the partnership add?
The commercial scope matters because DKSH combines market access, promotion and distribution rather than handling a single logistics role. That structure matches the model described in the September agreement, which reported 35 operating markets and 26,840 specialists in 2025, according to finanzen.ch.
Next reporting date
Simply Wall St lists February 16, 2027, as DKSH's next earnings date. The date follows a first-half 2026 result in which net income increased 10.00 percent year over year, leaving earnings execution as the clearest numerical test for the expansion strategy.
Last euro quote
DKSH was last at EUR 76.10 at Lang & Schwarz on October 12, 2026 at 11:00 p.m. CEST. The SIX-listed share uses ticker DKSH and belongs to the SPI. The further course of trading is shown by the continuously updated real-time quote of DKSH stock.
DKSH stock facts
- Company: DKSH Holding AG
- ISIN: CH0126673539
- Ticker: DKSH
- Primary exchange: SIX Swiss Exchange
- Price Lang & Schwarz (as of October 12, 2026, 11:00 p.m. CEST): EUR 76.10
- Sector / Industry: Industrials / Trading Companies and Distributors
- Index membership: SPI
Market context: Market report SMI.
